Last reviewed · How we verify
NCT03819842
Evaluating the Need for the Pseudophakic Intraoperative Abberrometry in Toric IOL Implantation
NA trial testing Pseudophakic Measurement in Cataract in 40 participants. Completed in 14 January 2019.
14 January 2019
Quick facts
| Lead sponsor | Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 19 March 2018 |
| Primary completion | 14 January 2019 |
| Estimated completion | 14 January 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Pseudophakic Measurement
Conditions studied
- Cataract — all drugs for Cataract →
- Nuclear Sclerosis — all drugs for Nuclear Sclerosis →
- Cortical Cataract — all drugs for Cortical Cataract →
- Posterior Subcapsular Cataract — all drugs for Posterior Subcapsular Cataract →
Sponsor
Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons
Who can join
30 and older, any sex, with Cataract or Nuclear Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine clinically significant difference in results obtained from cataract surgery using IA. One eye will receive aphakic measurements only and the fellow eye will receive aphakic and then pseudophakic measurements when implanting a toric IOL.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03819842
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03819842 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons
- Last refreshed: 20 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819842.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing